AstraZeneca signs deal to supply Canada 100k doses of COVID antibody therapy Evusheld
.
Over the current book year the total revenue from the company in Cambridge will be 43.2 billion GBp (consensus estimates). This is hugely more than 2021's revenue of 37.42 billion GBp.
Historical revenues and results Astrazeneca plus estimates 2021
The analysts expect for 2021 a net profit of 10.28 billion GBp. The majority of the analysts expects for this year a profit per share of 667 GBp. Based on this the price/earnings-ratio is 16.02.
Per share the analysts expect a dividend of 295 GBp per share. Thus the dividend yield equals 2.76 percent. The average dividend yield of the pharmaceutical companies equals a moderate 1.37 percent.
Based on the current number of shares Astrazeneca 's market capitalization equals 14029.8 billion GBp. 42
At 15.38 the stock trades 0.71 percent lower at 10688 GBp.Historical stock prices Astrazeneca period 2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
